-
1
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group N Engl J Med 339 19 1998 1349 1357
-
(1998)
N Engl J Med
, vol.339
, Issue.19
, pp. 1349-1357
-
-
-
2
-
-
11144355354
-
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
-
DOI 10.1056/NEJMoa040583
-
C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 15 2004 1495 1504 (Pubitemid 38477774)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.15
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
Joyal, S.V.7
Hill, K.A.8
Pfeffer, M.A.9
Skene, A.M.10
-
3
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
DOI 10.1161/01.CIR.0000133317.49796.0E
-
S.M. Grundy, J.I. Cleeman, and C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2 2004 227 239 (Pubitemid 38924592)
-
(2004)
Circulation
, vol.110
, Issue.2
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Bairey Merz, C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
4
-
-
3242667376
-
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality
-
DOI 10.1053/j.ajkd.2004.04.024, PII S0272638604006596
-
D.E. Weiner, H. Tighiouart, and P.C. Stark Kidney disease as a risk factor for recurrent cardiovascular disease and mortality Am J Kidney Dis 44 2 2004 198 206 (Pubitemid 38962547)
-
(2004)
American Journal of Kidney Diseases
, vol.44
, Issue.2
, pp. 198-206
-
-
Weiner, D.E.1
Tighiouart, H.2
Stark, P.C.3
Amin, M.G.4
MacLeod, B.5
Griffith, J.L.6
Salem, D.N.7
Levey, A.S.8
Sarnak, M.J.9
-
5
-
-
84865602423
-
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study
-
M. Tonelli, P. Muntner, and A. Lloyd Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study Lancet 2012
-
(2012)
Lancet
-
-
Tonelli, M.1
Muntner, P.2
Lloyd, A.3
-
6
-
-
76649140800
-
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry
-
C.S. Fox, P. Muntner, and A.Y. Chen Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry Circulation 121 3 2010 357 365
-
(2010)
Circulation
, vol.121
, Issue.3
, pp. 357-365
-
-
Fox, C.S.1
Muntner, P.2
Chen, A.Y.3
-
7
-
-
23944505195
-
The reasons for geographic and racial differences in stroke study: Objectives and design
-
DOI 10.1159/000086678
-
V.J. Howard, M. Cushman, and L. Pulley The Reasons for Geographic And Racial Differences in Stroke study: objectives and design Neuroepidemiology 25 3 2005 135 143 (Pubitemid 41207066)
-
(2005)
Neuroepidemiology
, vol.25
, Issue.3
, pp. 135-143
-
-
Howard, V.J.1
Cushman, M.2
Pulley, L.3
Gomez, C.R.4
Go, R.C.5
Prineas, R.J.6
Graham, A.7
Moy, C.S.8
Howard, G.9
-
9
-
-
70350245011
-
Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association for the Study of Obesity
-
K.G. Alberti, R.H. Eckel, and S.M. Grundy Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 16 2009 1640 1645
-
(2009)
Circulation
, vol.120
, Issue.16
, pp. 1640-1645
-
-
Alberti, K.G.1
Eckel, R.H.2
Grundy, S.M.3
-
10
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
-
(2009)
Ann Intern Med
, vol.150
, Issue.9
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
-
11
-
-
1642502319
-
National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
A.S. Levey, J. Coresh, and E. Balk National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2 2003 137 147
-
(2003)
Ann Intern Med
, vol.139
, Issue.2
, pp. 137-147
-
-
Levey, A.S.1
Coresh, J.2
Balk, E.3
-
12
-
-
0344444877
-
Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee
-
R.V. Luepker, F.S. Apple, and R.H. Christenson Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation 108 20 2003 2543 2549
-
(2003)
Circulation
, vol.108
, Issue.20
, pp. 2543-2549
-
-
Luepker, R.V.1
Apple, F.S.2
Christenson, R.H.3
-
13
-
-
57649111142
-
The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years
-
A. Rashidi, A.R. Sehgal, and M. Rahman The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years Am J Cardiol 102 12 2008 1668 1673
-
(2008)
Am J Cardiol
, vol.102
, Issue.12
, pp. 1668-1673
-
-
Rashidi, A.1
Sehgal, A.R.2
Rahman, M.3
-
14
-
-
82355175158
-
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation
-
S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 124 22 2011 2458 2473
-
(2011)
Circulation
, vol.124
, Issue.22
, pp. 2458-2473
-
-
Smith, Jr.S.C.1
Benjamin, E.J.2
Bonow, R.O.3
-
15
-
-
79959746706
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial
-
C. Baigent, M.J. Landray, and C. Reith The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
-
(2011)
Lancet
, vol.377
, Issue.9784
, pp. 2181-2192
-
-
Baigent, C.1
Landray, M.J.2
Reith, C.3
-
16
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 9493 2005 1267 1278
-
(2005)
Lancet
, vol.366
, Issue.9493
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
|